Oltipraz
SIGMA/O9389 - ≥98% (HPLC), powder
Synonym: 4-
CAS Number: 64224-21-1
Empirical Formula (Hill Notation): C8H6N2S3
Molecular Weight: 226.34
EC Number: 264-736-6
MDL Number: MFCD00868499
Linear Formula: C8H6N2S3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | red |
| form | powder |
| InChI | 1S/C8H6N2S3/c1-5-7(12-13- |
| InChI key | CKNAQFVBEHDJQV-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CC1=C(SSC1=S)c2cnccn2 |
| solubility | DMSO: >20 mg/mL |
| storage condition | protect from light |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Oltipraz is an activator of Nrf2. |
| Biochem/physiol Actions: | Oltipraz is an activator of Nrf2. Nrf2 (NF-E2-related factor 2) is a transcription factor that binds to antioxidant response elements (AREs) and activates these genes. Oltipraz activates Nrf2 and subsequently elevates expression of the detoxification genes encoding anti-oxidant and multidrug resistance-associated proteins to mediate its chemopreventive efficacy. |
| General description: | Oltipraz, a dithiol derivative, is a member of dithiolethiones class of organosulfur compounds. It has anti-tumor, antioxidative, anti- inflammatory and radioprotective properties. It provides protection from numerous carcinogens. Oltipraz functions as a schistosomicide. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


